Late Transition Metal Catalysts for Organic Synthesis
有机合成用后过渡金属催化剂
基本信息
- 批准号:9111922
- 负责人:
- 金额:$ 56.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAdverse effectsAlcoholsAlkanesulfonatesAlkenesAminationAminesApplications GrantsBiomedical ResearchCarbonCatalysisChemistryComplexCopperCouplingDevelopmentDrug IndustryEvolutionGoalsHandHealthIminesImprove AccessIndustryInvestigationKineticsLeadLigandsMedicineMetalsMethodologyMethodsNitrogenOrganic ChemistryOrganic SynthesisOxygenPharmaceutical ChemistryPharmacologic SubstancePhenolsPreparationProcessPropertyResolutionScienceTechniquesTemperatureTransition ElementsVertebral columnWorkanalogaryl halidebasecatalystcostdrug discoveryfunctional groupimprovedinventionnovelpi bondsensorsmall moleculeuser-friendly
项目摘要
DESCRIPTION (provided by applicant): The availability of functionalized molecules is of preeminent importance in the fields of organic and medicinal chemistry and to the pharmaceutical and related industries. Not only should compounds be accessible, but also the means to readily and predictably modify them to change their properties and/or eliminate side effects is of tremendous significance. The chemistry that is proposed in this grant application involves the invention or accentuation of techniques to access molecules that contain basic nitrogen centers as key structural features. Our prior work in this field has been incorporated into the everyday repertoire of synthetic organic chemists and has greatly impacted the field of organic synthesis, particularly in drug discovery in the pharmaceutical industry. In addition, we are proposing work on the synthesis in enantiomerically pure (single handed) form of a wide variety of amines from extremely simple (alkene) precursors. Essentially all modern small molecule medicines must now be sold in single-handed forms and the successful accomplishment of this feat can add to the cost of the medicinal agent. Also included are new methods for the preparation of nitrogen heterocycles. In many ways, compounds of this type form the backbone of the pharmaceutical industry. We also propose to carry out mechanistic studies on all of the chemistry included. Further, information gained from this work will help to understand the mechanism of the processes that are being developed in order to increase the efficiency of the methods that we are developing. Overall, the successful realization of the chemistry proposed in this grant application will have a major impact on the ability of chemists and those in auxiliary fields to develop new medicinally important, sensor or biologically relevant
compounds and materials that will move science forward.
描述(由申请人提供):功能化分子的可用性在有机和药物化学领域以及制药和相关行业中具有极其重要的意义。不仅化合物应该易于获取,而且容易且可预测地修饰它们以改变其性质和/或消除副作用的方法也具有巨大的意义。本资助申请中提出的化学涉及发明或强化获取含有碱性氮中心作为关键结构特征的分子的技术。我们之前在该领域的工作已融入有机合成化学家的日常工作中,并对有机合成领域产生了巨大影响,特别是在制药行业的药物发现方面。此外,我们还提议从极其简单的(烯烃)前体合成各种胺的对映体纯(单手)形式。基本上所有现代小分子药物现在都必须以单独的形式出售,而这一壮举的成功实现可能会增加药剂的成本。还包括制备氮杂环的新方法。在许多方面,此类化合物构成了制药工业的支柱。我们还建议对所有化学成分进行机理研究。此外,从这项工作中获得的信息将有助于理解正在开发的过程的机制,以提高我们正在开发的方法的效率。总体而言,本次拨款申请中提出的化学的成功实现将对化学家和辅助领域开发新的医学上重要的、传感器或生物相关的能力产生重大影响
将推动科学进步的化合物和材料。
项目成果
期刊论文数量(131)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Organometallic palladium reagents for cysteine bioconjugation.
- DOI:10.1038/nature15739
- 发表时间:2015-10-29
- 期刊:
- 影响因子:64.8
- 作者:Vinogradova EV;Zhang C;Spokoyny AM;Pentelute BL;Buchwald SL
- 通讯作者:Buchwald SL
Palladium-catalyzed amination of unprotected halo-7-azaindoles.
- DOI:10.1021/ol101928m
- 发表时间:2010-10-15
- 期刊:
- 影响因子:5.2
- 作者:Henderson, Jaclyn L.;McDermott, Sarah M.;Buchwald, Stephen L.
- 通讯作者:Buchwald, Stephen L.
Mechanistic studies on the copper-catalyzed N-arylation of amides.
- DOI:10.1021/ja0781893
- 发表时间:2009-01-14
- 期刊:
- 影响因子:15
- 作者:Strieter, Eric R.;Bhayana, Brijesh;Buchwald, Stephen L.
- 通讯作者:Buchwald, Stephen L.
Mild and general palladium-catalyzed synthesis of methyl aryl ethers enabled by the use of a palladacycle precatalyst.
- DOI:10.1021/ol401796v
- 发表时间:2013-08-02
- 期刊:
- 影响因子:5.2
- 作者:Cheung, Chi Wai;Buchwald, Stephen L.
- 通讯作者:Buchwald, Stephen L.
Enantioselective CuH-catalyzed anti-Markovnikov hydroamination of 1,1-disubstituted alkenes.
- DOI:10.1021/ja509786v
- 发表时间:2014-11-12
- 期刊:
- 影响因子:15
- 作者:Zhu, Shaolin;Buchwald, Stephen L.
- 通讯作者:Buchwald, Stephen L.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN L BUCHWALD其他文献
STEPHEN L BUCHWALD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN L BUCHWALD', 18)}}的其他基金
LATE TRANSITION METAL CATALYSTS FOR ORGANIC SYNTHESIS
用于有机合成的后过渡金属催化剂
- 批准号:
6386994 - 财政年份:1998
- 资助金额:
$ 56.96万 - 项目类别:
LATE TRANSITION METAL CATALYSTS FOR ORGANIC SYNTHESIS
用于有机合成的后过渡金属催化剂
- 批准号:
6788016 - 财政年份:1998
- 资助金额:
$ 56.96万 - 项目类别:
LATE TRANSITION METAL CATALYSTS FOR ORGANIC SYNTHESIS
用于有机合成的后过渡金属催化剂
- 批准号:
6697011 - 财政年份:1998
- 资助金额:
$ 56.96万 - 项目类别:
Late Transition Metal Catalysts for Organic Synthesis
有机合成用后过渡金属催化剂
- 批准号:
7138861 - 财政年份:1998
- 资助金额:
$ 56.96万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 56.96万 - 项目类别:
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 56.96万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 56.96万 - 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
- 批准号:
10638221 - 财政年份:2023
- 资助金额:
$ 56.96万 - 项目类别:
Gut Microbiota-Mediated Inflammatory Interactions Between Alcohol Use Disorders and HIV Infection
肠道微生物介导的酒精使用障碍和 HIV 感染之间的炎症相互作用
- 批准号:
10838766 - 财政年份:2023
- 资助金额:
$ 56.96万 - 项目类别: